Magnetically active pNIPAM nanosystems as temperature-sensitive biocompatible structures for controlled drug delivery

Beatriz Garcia-Pinel1,2,3, Alicia Ortega-Rodríguez4, Cristina Porras-Alcalá4

  • 1Institute of Biopathology and Regenerative Medicine (IBIMER), Center of Biomedical Research (CIBM), University of Granada, Granada, Spain.

Summary

New magnetic nanoparticles offer controlled drug delivery for colon cancer. These biocompatible poly(N-isopropylacrylamide) (pNIPAM) nanosystems effectively deliver 5-fluorouracil (5FU) and oxaliplatin (OXA), showing promise for improved cancer treatment.

Related Concept Videos